Reduced phytosterol oil composition
By using sn-2 palmitate oil (OPO) to source palmitic acid, the process achieves an infant formula oil blend with reduced phytosterols and human breast milk-like fatty acids, addressing inefficiencies and costs in existing treatments.
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- AAK AB(PUBL)
- Filing Date
- 2025-12-11
- Publication Date
- 2026-06-18
AI Technical Summary
Existing processes for reducing phytosterol content in vegetable oils for infant formulas result in significant product losses and altered fatty acid profiles, leading to increased costs and complexity, and it is challenging to achieve a phytosterol content below 500 ppm without multiple treatments, which can disrupt the oil's regulatory compliance and similarity to human breast milk fatty acid profiles.
Incorporating sn-2 palmitate oil (OPO) as a source of palmitic acid, allowing for a single treatment of soybean and sunflower oils to reduce phytosterol content, while maintaining a fatty acid profile similar to human breast milk, thereby minimizing product losses and process complexity.
The solution provides an oil composition with less than 500 ppm phytosterol content, mimicking human breast milk fatty acids, while reducing process complexity and costs by minimizing product losses and ensuring regulatory compliance.
Smart Images

Figure 1 
Figure 2 
Figure 3